Merck: A Golden Buying Opportunity (NYSE:MRK)

In my opinion, Merck & Co., Inc.'s (NYSE: MRK ) business remains strong, profitable and well-managed. Merck’s cancer drug Keytruda remains one of the best-selling medicines in the world. The company’s long-term outlook is alsoI am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield and real estate industries. With over a decade of experience in finance, I have led numerous complex due diligence efforts and M&A transactions, both domestically and internationally.In rec ...